|
|
||
![]() |
||
| HELP | ||
|
On Order$186.25
New Hardcover
Currently out of stock.
available for shipping or prepaid pickup only
Adenosine Receptors and Parkinson's Diseaseby Hiroshi Kase
Synopses & ReviewsPublisher Comments:This book is the first definitive overview on adenosine receptor antagonists and their application to the treatment of Parkinson's Disease. The effect of these novel non-dopamine drugs on "vitro" and "in vivo" systems clearly shows their potential for the treatment of this debilitating disease. This book covers how the Parkinson's disease antagonist drug, A2A, has been researched, developed, and tested. It is an essential book for researchers interested in the basal ganglia, purine biology, and Parkinson's Disease. <BR>Key Features<BR>* Discusses the discovery and development of a novel non-dopaminomimetic agent for Parkinson's disease<BR>* Provides the first definitive overview of adenosine antagonists and their role in the treatment of Parkinson's disease<BR>* Presents a new mechanism of action of adenosine A2A receptor antagonists in motor function<BR>Proposes a hypothesis of adenosine A2A receptor function in the striatum<BR>* Comprehensive overview of adenosine, its receptor subtypes, their antagonists/agonists from biochemistry, molecular biology, medicinal chemistry, physiology, pharmacology, and neurochemistry viewpoints
Book News Annotation:Offers an overview of adenosine antagonists and Parkinson's disease.
Delineates a novel mechanism and concept of adenosine receptor
antagonists, explaining groundbreaking research in biochemistry,
molecular biology, medicinal chemistry, electrophysiology,
pharmacology, and neurochemistry. Discusses the development of a
novel non-dopaminomimetic agent for Parkinson's disease, presents a
new mechanism of action of adenosine receptor antagonists in motor
function, and proposes a hypothesis of adenosine receptor function in
the striatum. Kase is involved in pharmaceutical research and
development at a Japanese company; Richardson teaches pharmacology at
the University of Cambridge; Jenner is affiliated with the
Neurodegenerative Diseases Research Center at King's College London.
Annotation c. Book News, Inc., Portland, OR (booknews.com) Synopsis:try to delineate a novel mechanism and concept of adenosine A2A receptor antagonists for the therapeutic approach to Parkinson's disease. Synopsis:and concept of adenosine A2A receptor antagonists for the therapeutic approach to Parkinson's disease. Table of Contentslites in Movement Disorders.
What Our Readers Are SayingBe the first to add a comment for a chance to win!Product Details
Related Aisles | |||||||||
|
| ||||||||||
|
|
||||||||||